Neurologic side effects of mefloquine. Implications for prevention and self administration
Hellgren, U.; Rombo, L.
Lakartidningen 86(52): 4592
1989
ISSN/ISBN: 0023-7205 PMID: 2607865 Document Number: 337622
Document emailed within 1 workday
Related Documents
Minei-Rachmilewitz, T. 1999: Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam) Harefuah 137(1-2): 25-27; 87Combarnous, F.; Fouque, D.; Chossegros, P.; Boulieu, R.; Laville, M.; Zech, P. 1994: Neurologic side-effects of ganciclovir Clinical Nephrology 42(4): 279-280
Bygbjerg, I.C.; Rønn, A.M. 1999: Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. a case after six weeks of initiating and lasting six months Ugeskrift for Laeger 161(10): 1422-1423
Andrejak, M.; Schmit, J.L.; Tondriaux, A.; Hary, L.; Debailleux, S.; Moore, N. 1992: Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin Therapie 47(5): 415-418
Panhuysen, L.H. 1970: Undesirable side effects of LSD administration Nederlands Tijdschrift Voor Geneeskunde 114(17): 723-727
Veglia, L.; Basile, F.; Guerricchio, G. 1975: Some side-effects of bunaftine in direct venous administration Bollettino Della Societa Italiana di Cardiologia 20(4): 371-376
Ninane, J.; Mahieu, P.; Hassoun, A.; Goenen, M. 1978: Unusual side effects following administration of dipyrone and acetylsalicylic acid Acta Clinica Belgica 33(5): 292-295
De Bie, J.H. 1992: Serious psychological side effects in children due to administration of high dosage deptropine Nederlands Tijdschrift Voor Geneeskunde 136(32): 1574
Kovalev, V.K. 1977: Side effects of antibiotics and their prevention Fel'dsher i Akusherka 42(2): 46-48
Litzman, J.; Wiedermannová, D.; Lokaj, J.; Král, V. 1992: Side effects of administration of gamma globulin preparations in patients with primary agammaglobulinemia Vnitrni Lekarstvi 38(5): 490-494
Taguchi, O.; Yamakami, T.; Machishi, M.; Gabazza, E.C.; Ibata, H.; Tsutsui, K.; Suzuki, S. 1992: Pharmacokinetic study and side effects of chronic daily administration of oral etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2005-2009
Alexander, L.J.; Bowerman, L.; Thompson, L.R. 1985: The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population Journal of the American Optometric Association 56(11): 872-876
Gol'dovskaia, I.L. 1990: Prevention and correction of the side effects of psychopharmacologic agents on the eye Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(2): 90-94
Nchimi, C.; Mottet, C.; Petignat, P-Auguste.; Gobin, N. 2019: PPI : an update on side effects, use in prevention and withdrawal strategy Revue Medicale Suisse 15(661): 1551-1555
Vargas, B.; García, G.; Prado, G.; Castellón, P.; Vásquez, F.; Aramayo, S.; Zapata, I.; López, N.; Candia, S.; Mondaca, L. 1986: Urethrocystography, side effects and prevention of secondary infections Revista Chilena de Pediatria 57(1): 26-30
Kazim, M.; Puri, S.K.; Dutta, G.P. 1979: Chemotherapeutic studies with mefloquine and selection of a mefloquine resistant strain of Plasmodium berghei Indian Journal of Medical Research 70(Suppl): 95-102
Bornstein, M.; Buser, D.; Filippi, A. 2001: Concepts of prevention and therapy of radiation-induced side effects Schweizer Monatsschrift für Zahnmedizin 111(8): 962-977
Tilsner, V. 1970: Electrolyte therapy for prevention and treatment of glycoside side effects Münchener Medizinische Wochenschrift 112(7): 291-297
Pavelka, K. 1985: Prevention of adverse side-effects of nonsteroidal antirheumatic agents Vnitrni Lekarstvi 31(7): 706-710
Pander Maat, H.; Klaassen, R. 1996: The effect of the wording of information about side effects on patients' interpretation of reported side effects Nederlands Tijdschrift Voor Geneeskunde 140(8): 424-427